TY - JOUR AU - Fuster, M. M. AU - Esko, J. D. PY - 2005 DA - 2005// TI - The sweet and sour of cancer: glycans as novel therapeutic targets JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1649 DO - 10.1038/nrc1649 ID - Fuster2005 ER - TY - JOUR AU - Weis, W. I. AU - Drickamer, K. PY - 1996 DA - 1996// TI - Structural basis of lectin-carbohydrate recognition JO - Annu Rev Biochem VL - 65 UR - https://doi.org/10.1146/annurev.bi.65.070196.002301 DO - 10.1146/annurev.bi.65.070196.002301 ID - Weis1996 ER - TY - JOUR AU - Banh, A. AU - Zhang, J. AU - Cao, H. AU - Bouley, D. M. AU - Kwok, S. AU - Kong, C. PY - 2011 DA - 2011// TI - Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-4157 DO - 10.1158/0008-5472.CAN-10-4157 ID - Banh2011 ER - TY - JOUR AU - Tang, D. AU - Yuan, Z. AU - Xue, X. AU - Lu, Z. AU - Zhang, Y. AU - Wang, H. PY - 2012 DA - 2012// TI - High expression of galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26290 DO - 10.1002/ijc.26290 ID - Tang2012 ER - TY - JOUR AU - Miyazaki, K. AU - Sakuma, K. AU - Kawamura, Y. I. AU - Izawa, M. AU - Ohmori, K. AU - Mitsuki, M. PY - 2012 DA - 2012// TI - Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9 JO - J Immunol VL - 188 UR - https://doi.org/10.4049/jimmunol.1100605 DO - 10.4049/jimmunol.1100605 ID - Miyazaki2012 ER - TY - JOUR AU - Cimmino, F. AU - Schulte, J. H. AU - Zollo, M. AU - Koster, J. AU - Versteeg, R. AU - Iolascon, A. PY - 2009 DA - 2009// TI - Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness JO - Oncogene VL - 28 UR - https://doi.org/10.1038/onc.2009.70 DO - 10.1038/onc.2009.70 ID - Cimmino2009 ER - TY - JOUR AU - Kamijo, T. AU - Nakagawara, A. PY - 2012 DA - 2012// TI - Molecular and genetic bases of neuroblastoma JO - Int J Clin Oncol VL - 17 UR - https://doi.org/10.1007/s10147-012-0415-7 DO - 10.1007/s10147-012-0415-7 ID - Kamijo2012 ER - TY - JOUR AU - Liu, Y. L. AU - Miser, J. S. AU - Hsu, W. M. PY - 2014 DA - 2014// TI - Risk-directed therapy and research in neuroblastoma JO - J Formos Med Assoc VL - 113 UR - https://doi.org/10.1016/j.jfma.2014.11.001 DO - 10.1016/j.jfma.2014.11.001 ID - Liu2014 ER - TY - JOUR AU - Liu, Y. L. AU - Lo, W. C. AU - Chiang, C. J. AU - Yang, Y. W. AU - Lu, M. Y. AU - Hsu, W. M. PY - 2015 DA - 2015// TI - Incidence of cancer in children aged 0-14 years in Taiwan, 1996-2010 JO - Cancer Epidemiol VL - 39 UR - https://doi.org/10.1016/j.canep.2014.11.010 DO - 10.1016/j.canep.2014.11.010 ID - Liu2015 ER - TY - JOUR AU - Brodeur, G. M. AU - Pritchard, J. AU - Berthold, F. AU - Carlsen, N. L. AU - Castel, V. AU - Castelberry, R. P. PY - 1993 DA - 1993// TI - Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment JO - J Clin Oncol VL - 11 ID - Brodeur1993 ER - TY - JOUR AU - Castleberry, R. P. PY - 1997 DA - 1997// TI - Neuroblastoma JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(97)00308-0 DO - 10.1016/S0959-8049(97)00308-0 ID - Castleberry1997 ER - TY - JOUR AU - Ahmed, M. AU - Cheung, N. K. PY - 2014 DA - 2014// TI - Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy JO - FEBS Lett VL - 588 UR - https://doi.org/10.1016/j.febslet.2013.11.030 DO - 10.1016/j.febslet.2013.11.030 ID - Ahmed2014 ER - TY - JOUR AU - Chiang, C. H. AU - Wang, C. H. AU - Chang, H. C. AU - More, S. V. AU - Li, W. S. AU - Hung, W. C. PY - 2010 DA - 2010// TI - A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling JO - J Cell Physiol VL - 223 ID - Chiang2010 ER - TY - JOUR AU - Hsu, C. C. AU - Lin, T. W. AU - Chang, W. W. AU - Wu, C. Y. AU - Lo, W. H. AU - Wang, P. H. PY - 2005 DA - 2005// TI - Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids JO - Gynecol Oncol VL - 96 UR - https://doi.org/10.1016/j.ygyno.2004.10.010 DO - 10.1016/j.ygyno.2004.10.010 ID - Hsu2005 ER - TY - JOUR AU - Carr, A. AU - Mazorra, Z. AU - Alonso, D. F. AU - Mesa, C. AU - Valiente, O. AU - Gomez, D. E. PY - 2001 DA - 2001// TI - A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo JO - Melanoma Res VL - 11 UR - https://doi.org/10.1097/00008390-200106000-00003 DO - 10.1097/00008390-200106000-00003 ID - Carr2001 ER - TY - JOUR AU - Alfonso, S. AU - Diaz, R. M. AU - Torre, A. AU - Santiesteban, E. AU - Aguirre, F. AU - Perez, K. PY - 2007 DA - 2007// TI - 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients JO - Cancer Biol Ther VL - 6 UR - https://doi.org/10.4161/cbt.6.12.5000 DO - 10.4161/cbt.6.12.5000 ID - Alfonso2007 ER - TY - JOUR AU - Diaz, A. AU - Alfonso, M. AU - Alonso, R. AU - Saurez, G. AU - Troche, M. AU - Catala, M. PY - 2003 DA - 2003// TI - Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides JO - Clin Immunol VL - 107 UR - https://doi.org/10.1016/S1521-6616(03)00036-6 DO - 10.1016/S1521-6616(03)00036-6 ID - Diaz2003 ER - TY - JOUR AU - Ni, X. AU - Jorgensen, J. L. AU - Goswami, M. AU - Challagundla, P. AU - Decker, W. K. AU - Kim, Y. H. PY - 2015 DA - 2015// TI - Reduction of regulatory T cells by mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sezary syndrome JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-0830 DO - 10.1158/1078-0432.CCR-14-0830 ID - Ni2015 ER - TY - JOUR AU - Ishida, T. AU - Joh, T. AU - Uike, N. AU - Yamamoto, K. AU - Utsunomiya, A. AU - Yoshida, S. PY - 2012 DA - 2012// TI - Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.37.3472 DO - 10.1200/JCO.2011.37.3472 ID - Ishida2012 ER - TY - JOUR AU - Cheresh, D. A. AU - Pierschbacher, M. D. AU - Herzig, M. A. AU - Mujoo, K. PY - 1986 DA - 1986// TI - Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins JO - J Cell Biol VL - 102 UR - https://doi.org/10.1083/jcb.102.3.688 DO - 10.1083/jcb.102.3.688 ID - Cheresh1986 ER - TY - JOUR AU - Helenius, A. AU - Aebi, M. PY - 2001 DA - 2001// TI - Intracellular functions of N-linked glycans JO - Science VL - 291 UR - https://doi.org/10.1126/science.291.5512.2364 DO - 10.1126/science.291.5512.2364 ID - Helenius2001 ER - TY - JOUR AU - Tarp, M. A. AU - Clausen, H. PY - 2008 DA - 2008// TI - Mucin-type O-glycosylation and its potential use in drug and vaccine development JO - Biochim Biophys Acta VL - 1780 UR - https://doi.org/10.1016/j.bbagen.2007.09.010 DO - 10.1016/j.bbagen.2007.09.010 ID - Tarp2008 ER - TY - JOUR AU - Reis, C. A. AU - Osorio, H. AU - Silva, L. AU - Gomes, C. AU - David, L. PY - 2010 DA - 2010// TI - Alterations in glycosylation as biomarkers for cancer detection JO - J Clin Pathol VL - 63 UR - https://doi.org/10.1136/jcp.2009.071035 DO - 10.1136/jcp.2009.071035 ID - Reis2010 ER - TY - JOUR AU - Tian, E. AU - Hagen, K. G. PY - 2009 DA - 2009// TI - Recent insights into the biological roles of mucin-type O-glycosylation JO - Glycoconj J VL - 26 UR - https://doi.org/10.1007/s10719-008-9162-4 DO - 10.1007/s10719-008-9162-4 ID - Tian2009 ER - TY - JOUR AU - Hagen, K. G. AU - Fritz, T. A. AU - Tabak, L. A. PY - 2003 DA - 2003// TI - All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases JO - Glycobiology VL - 13 UR - https://doi.org/10.1093/glycob/cwg007 DO - 10.1093/glycob/cwg007 ID - Hagen2003 ER - TY - JOUR AU - Cao, Y. AU - Stosiek, P. AU - Springer, G. F. AU - Karsten, U. PY - 1996 DA - 1996// TI - Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study JO - Histochem Cell Biol VL - 106 UR - https://doi.org/10.1007/BF02484401 DO - 10.1007/BF02484401 ID - Cao1996 ER - TY - JOUR AU - Schwientek, T. AU - Nomoto, M. AU - Levery, S. B. AU - Merkx, G. AU - Kessel, A. G. AU - Bennett, E. P. PY - 1999 DA - 1999// TI - Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel beta1,6-N-acetylglucosaminyltransferase forming core 2 and core 4 JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.8.4504 DO - 10.1074/jbc.274.8.4504 ID - Schwientek1999 ER - TY - JOUR AU - Iwai, T. AU - Inaba, N. AU - Naundorf, A. AU - Zhang, Y. AU - Gotoh, M. AU - Iwasaki, H. PY - 2002 DA - 2002// TI - Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans JO - J Biol Chem VL - 277 UR - https://doi.org/10.1074/jbc.M112457200 DO - 10.1074/jbc.M112457200 ID - Iwai2002 ER - TY - CHAP AU - Brockhausen, I. AU - Schachter, H. AU - Stanley, P. ED - Varki, A. ED - Cummings, R. D. ED - Esko, J. D. ED - Freeze, H. H. ED - Stanley, P. ED - Bertozzi, C. R. PY - 2009 DA - 2009// TI - O-GalNAc glycans BT - Essentials of glycobiology PB - Cold Spring CY - Harbor ID - Brockhausen2009 ER - TY - JOUR AU - Rabinovich, G. A. AU - Kooyk, Y. AU - Cobb, B. A. PY - 2012 DA - 2012// TI - Glycobiology of immune responses JO - Ann N Y Acad Sci VL - 1253 UR - https://doi.org/10.1111/j.1749-6632.2012.06492.x DO - 10.1111/j.1749-6632.2012.06492.x ID - Rabinovich2012 ER - TY - JOUR AU - Freire-de-Lima, L. PY - 2014 DA - 2014// TI - Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00059 DO - 10.3389/fonc.2014.00059 ID - Freire-de-Lima2014 ER - TY - JOUR AU - Beheshti Zavareh, R. AU - Lau, K. S. AU - Hurren, R. AU - Datti, A. AU - Ashline, D. J. AU - Gronda, M. PY - 2008 DA - 2008// TI - Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6833 DO - 10.1158/0008-5472.CAN-07-6833 ID - Beheshti Zavareh2008 ER - TY - JOUR AU - Ogata, S. I. AU - Muramatsu, T. AU - Kobata, A. PY - 1976 DA - 1976// TI - New structural characteristic of the large glycopeptides from transformed cells JO - Nature VL - 259 UR - https://doi.org/10.1038/259580a0 DO - 10.1038/259580a0 ID - Ogata1976 ER - TY - JOUR AU - Lau, K. S. AU - Dennis, J. W. PY - 2008 DA - 2008// TI - N-Glycans in cancer progression JO - Glycobiology VL - 18 UR - https://doi.org/10.1093/glycob/cwn071 DO - 10.1093/glycob/cwn071 ID - Lau2008 ER - TY - JOUR AU - Fernandes, B. AU - Sagman, U. AU - Auger, M. AU - Demetrio, M. AU - Dennis, J. W. PY - 1991 DA - 1991// TI - Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia JO - Cancer Res VL - 51 ID - Fernandes1991 ER - TY - JOUR AU - Murata, K. AU - Miyoshi, E. AU - Kameyama, M. AU - Ishikawa, O. AU - Kabuto, T. AU - Sasaki, Y. PY - 2000 DA - 2000// TI - Expression of N-acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis JO - Clin Cancer Res VL - 6 ID - Murata2000 ER - TY - JOUR AU - Dosaka-Akita, H. AU - Miyoshi, E. AU - Suzuki, O. AU - Itoh, T. AU - Katoh, H. AU - Taniguchi, N. PY - 2004 DA - 2004// TI - Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-1047-3 DO - 10.1158/1078-0432.CCR-1047-3 ID - Dosaka-Akita2004 ER - TY - JOUR AU - Inamori, K. AU - Gu, J. AU - Ohira, M. AU - Kawasaki, A. AU - Nakamura, Y. AU - Nakagawa, T. PY - 2006 DA - 2006// TI - High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis JO - FEBS Lett VL - 580 UR - https://doi.org/10.1016/j.febslet.2005.12.089 DO - 10.1016/j.febslet.2005.12.089 ID - Inamori2006 ER - TY - JOUR AU - Gu, J. AU - Sato, Y. AU - Kariya, Y. AU - Isaji, T. AU - Taniguchi, N. AU - Fukuda, T. PY - 2009 DA - 2009// TI - A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions JO - J Proteome Res VL - 8 UR - https://doi.org/10.1021/pr800674g DO - 10.1021/pr800674g ID - Gu2009 ER - TY - JOUR AU - Dosaka-Akita, H. AU - Kinoshita, I. AU - Yamazaki, K. AU - Izumi, H. AU - Itoh, T. AU - Katoh, H. PY - 2002 DA - 2002// TI - N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers JO - Br J Cancer VL - 87 UR - https://doi.org/10.1038/sj.bjc.6600536 DO - 10.1038/sj.bjc.6600536 ID - Dosaka-Akita2002 ER - TY - JOUR AU - Yamamoto, S. AU - Nakamori, S. AU - Tsujie, M. AU - Takahashi, Y. AU - Nagano, H. AU - Dono, K. PY - 2004 DA - 2004// TI - Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas JO - Pathobiology VL - 71 UR - https://doi.org/10.1159/000072957 DO - 10.1159/000072957 ID - Yamamoto2004 ER - TY - JOUR AU - Park, J. H. AU - Nishidate, T. AU - Kijima, K. AU - Ohashi, T. AU - Takegawa, K. AU - Fujikane, T. PY - 2010 DA - 2010// TI - Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3911 DO - 10.1158/0008-5472.CAN-09-3911 ID - Park2010 ER - TY - JOUR AU - Park, J. H. AU - Katagiri, T. AU - Chung, S. AU - Kijima, K. AU - Nakamura, Y. PY - 2011 DA - 2011// TI - Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin JO - Neoplasia VL - 13 UR - https://doi.org/10.1593/neo.101440 DO - 10.1593/neo.101440 ID - Park2011 ER - TY - JOUR AU - Wagner, K. W. AU - Punnoose, E. A. AU - Januario, T. AU - Lawrence, D. A. AU - Pitti, R. M. AU - Lancaster, K. PY - 2007 DA - 2007// TI - Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1627 DO - 10.1038/nm1627 ID - Wagner2007 ER - TY - JOUR AU - Itzkowitz, S. H. AU - Yuan, M. AU - Montgomery, C. K. AU - Kjeldsen, T. AU - Takahashi, H. K. AU - Bigbee, W. L. PY - 1989 DA - 1989// TI - Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer JO - Cancer Res VL - 49 ID - Itzkowitz1989 ER - TY - JOUR AU - Noguchi, M. AU - Nakajima, T. AU - Hirohashi, S. AU - Akiba, T. AU - Shimosato, Y. PY - 1989 DA - 1989// TI - Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with anti-surfactant apoprotein, anti-Lewisa, and anti-Tn antibodies JO - Hum Pathol VL - 20 UR - https://doi.org/10.1016/0046-8177(89)90202-5 DO - 10.1016/0046-8177(89)90202-5 ID - Noguchi1989 ER - TY - JOUR AU - David, L. AU - Nesland, J. M. AU - Clausen, H. AU - Carneiro, F. AU - Sobrinho-Simoes, M. PY - 1992 DA - 1992// TI - Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases JO - APMIS Suppl VL - 27 ID - David1992 ER - TY - JOUR AU - Kaur, S. AU - Kumar, S. AU - Momi, N. AU - Sasson, A. R. AU - Batra, S. K. PY - 2013 DA - 2013// TI - Mucins in pancreatic cancer and its microenvironment JO - Nat Rev Gastroenterol Hepatol VL - 10 UR - https://doi.org/10.1038/nrgastro.2013.120 DO - 10.1038/nrgastro.2013.120 ID - Kaur2013 ER - TY - JOUR AU - Schultz, M. J. AU - Swindall, A. F. AU - Bellis, S. L. PY - 2012 DA - 2012// TI - Regulation of the metastatic cell phenotype by sialylated glycans JO - Cancer Metastasis Rev VL - 31 UR - https://doi.org/10.1007/s10555-012-9359-7 DO - 10.1007/s10555-012-9359-7 ID - Schultz2012 ER - TY - JOUR AU - Koike, T. AU - Kimura, N. AU - Miyazaki, K. AU - Yabuta, T. AU - Kumamoto, K. AU - Takenoshita, S. PY - 2004 DA - 2004// TI - Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0402088101 DO - 10.1073/pnas.0402088101 ID - Koike2004 ER - TY - JOUR AU - Marcos, N. T. AU - Bennett, E. P. AU - Gomes, J. AU - Magalhaes, A. AU - Gomes, C. AU - David, L. PY - 2011 DA - 2011// TI - ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues JO - Front Biosci (Elite Ed) VL - 3 ID - Marcos2011 ER - TY - JOUR AU - Ju, T. AU - Lanneau, G. S. AU - Gautam, T. AU - Wang, Y. AU - Xia, B. AU - Stowell, S. R. PY - 2008 DA - 2008// TI - Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2345 DO - 10.1158/0008-5472.CAN-07-2345 ID - Ju2008 ER - TY - JOUR AU - Hollingsworth, M. A. AU - Swanson, B. J. PY - 2004 DA - 2004// TI - Mucins in cancer: protection and control of the cell surface JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1251 DO - 10.1038/nrc1251 ID - Hollingsworth2004 ER - TY - JOUR AU - Amano, M. AU - Galvan, M. AU - He, J. AU - Baum, L. G. PY - 2003 DA - 2003// TI - The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M209595200 DO - 10.1074/jbc.M209595200 ID - Amano2003 ER - TY - JOUR AU - Patnaik, S. K. AU - Potvin, B. AU - Carlsson, S. AU - Sturm, D. AU - Leffler, H. AU - Stanley, P. PY - 2006 DA - 2006// TI - Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells JO - Glycobiology VL - 16 UR - https://doi.org/10.1093/glycob/cwj063 DO - 10.1093/glycob/cwj063 ID - Patnaik2006 ER - TY - JOUR AU - Takenaka, Y. AU - Fukumori, T. AU - Raz, A. PY - 2004 DA - 2004// TI - Galectin-3 and metastasis JO - Glycoconj J VL - 19 UR - https://doi.org/10.1023/B:GLYC.0000014084.01324.15 DO - 10.1023/B:GLYC.0000014084.01324.15 ID - Takenaka2004 ER - TY - JOUR AU - Baldus, S. E. AU - Monig, S. P. AU - Hanisch, F. G. AU - Zirbes, T. K. AU - Flucke, U. AU - Oelert, S. PY - 2002 DA - 2002// TI - Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma JO - Histopathology VL - 40 UR - https://doi.org/10.1046/j.1365-2559.2002.01389.x DO - 10.1046/j.1365-2559.2002.01389.x ID - Baldus2002 ER - TY - JOUR AU - Chaturvedi, P. AU - Singh, A. P. AU - Batra, S. K. PY - 2008 DA - 2008// TI - Structure, evolution, and biology of the MUC4 mucin JO - FASEB J VL - 22 UR - https://doi.org/10.1096/fj.07-9673rev DO - 10.1096/fj.07-9673rev ID - Chaturvedi2008 ER - TY - JOUR AU - Chen, S. H. AU - Dallas, M. R. AU - Balzer, E. M. AU - Konstantopoulos, K. PY - 2012 DA - 2012// TI - Mucin 16 is a functional selectin ligand on pancreatic cancer cells JO - FASEB J VL - 26 UR - https://doi.org/10.1096/fj.11-195669 DO - 10.1096/fj.11-195669 ID - Chen2012 ER - TY - JOUR AU - Singh, R. AU - Campbell, B. J. AU - Yu, L. G. AU - Fernig, D. G. AU - Milton, J. D. AU - Goodlad, R. A. PY - 2001 DA - 2001// TI - Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44 JO - Glycobiology VL - 11 UR - https://doi.org/10.1093/glycob/11.7.587 DO - 10.1093/glycob/11.7.587 ID - Singh2001 ER - TY - JOUR AU - Hauselmann, I. AU - Borsig, L. PY - 2014 DA - 2014// TI - Altered tumor-cell glycosylation promotes metastasis JO - Front Oncol VL - 4 UR - https://doi.org/10.3389/fonc.2014.00028 DO - 10.3389/fonc.2014.00028 ID - Hauselmann2014 ER - TY - JOUR AU - Krause, T. AU - Turner, G. A. PY - 1999 DA - 1999// TI - Are selectins involved in metastasis? JO - Clin Exp Metastasis VL - 17 UR - https://doi.org/10.1023/A:1006626500852 DO - 10.1023/A:1006626500852 ID - Krause1999 ER - TY - JOUR AU - Yoon, K. J. AU - Phelps, D. A. AU - Bush, R. A. AU - Remack, J. S. AU - Billups, C. A. AU - Khoury, J. D. PY - 2008 DA - 2008// TI - ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0003629 DO - 10.1371/journal.pone.0003629 ID - Yoon2008 ER - TY - JOUR AU - Feduska, J. M. AU - Garcia, P. L. AU - Brennan, S. B. AU - Bu, S. AU - Council, L. N. AU - Yoon, K. J. PY - 2013 DA - 2013// TI - N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-261 DO - 10.1186/1471-2407-13-261 ID - Feduska2013 ER - TY - JOUR AU - Passoni, L. AU - Longo, L. AU - Collini, P. AU - Coluccia, A. M. AU - Bozzi, F. AU - Podda, M. PY - 2009 DA - 2009// TI - Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-4419 DO - 10.1158/0008-5472.CAN-08-4419 ID - Passoni2009 ER - TY - JOUR AU - Schleiermacher, G. AU - Javanmardi, N. AU - Bernard, V. AU - Leroy, Q. AU - Cappo, J. AU - Rio Frio, T. PY - 2014 DA - 2014// TI - Emergence of new ALK mutations at relapse of neuroblastoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.0674 DO - 10.1200/JCO.2013.54.0674 ID - Schleiermacher2014 ER - TY - JOUR AU - Grosso, F. AU - Mariano, M. AU - Passoni, L. AU - Luksch, R. AU - Tonini, G. P. AU - Longo, L. PY - 2011 DA - 2011// TI - Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-525 DO - 10.1186/1471-2407-11-525 ID - Grosso2011 ER - TY - STD TI - Siaw JT, Wan H, Pfeifer K, Rivera VM, Guan J, Palmer RH, et al. Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice. Oncotarget. 2016;7(20):29011–22. ID - ref68 ER - TY - JOUR AU - Iragavarapu, C. AU - Mustafa, M. AU - Akinleye, A. AU - Furqan, M. AU - Mittal, V. AU - Cang, S. PY - 2015 DA - 2015// TI - Novel ALK inhibitors in clinical use and development JO - J Hematol Oncol VL - 8 UR - https://doi.org/10.1186/s13045-015-0122-8 DO - 10.1186/s13045-015-0122-8 ID - Iragavarapu2015 ER - TY - JOUR AU - Zhang, Y. AU - Iwasaki, H. AU - Wang, H. AU - Kudo, T. AU - Kalka, T. B. AU - Hennet, T. PY - 2003 DA - 2003// TI - Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M203094200 DO - 10.1074/jbc.M203094200 ID - Zhang2003 ER - TY - JOUR AU - Berois, N. AU - Blanc, E. AU - Ripoche, H. AU - Mergui, X. AU - Trajtenberg, F. AU - Cantais, S. PY - 2006 DA - 2006// TI - ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma JO - Clin Chem VL - 52 UR - https://doi.org/10.1373/clinchem.2006.067975 DO - 10.1373/clinchem.2006.067975 ID - Berois2006 ER - TY - JOUR AU - Ferrandis, E. AU - Silva, J. AU - Riou, G. AU - Benard, I. PY - 1994 DA - 1994// TI - Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse JO - Cancer Res VL - 54 ID - Ferrandis1994 ER - TY - JOUR AU - Berois, N. AU - Gattolliat, C. H. AU - Barrios, E. AU - Capandeguy, L. AU - Douc-Rasy, S. AU - Valteau-Couanet, D. PY - 2013 DA - 2013// TI - GALNT9 gene expression is a prognostic marker in neuroblastoma patients JO - Clin Chem VL - 59 UR - https://doi.org/10.1373/clinchem.2012.192328 DO - 10.1373/clinchem.2012.192328 ID - Berois2013 ER - TY - JOUR AU - Mitoma, J. AU - Petryniak, B. AU - Hiraoka, N. AU - Yeh, J. C. AU - Lowe, J. B. AU - Fukuda, M. PY - 2003 DA - 2003// TI - Extended core 1 and core 2 branched O-glycans differentially modulate sialyl Lewis X-type L-selectin ligand activity JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M212756200 DO - 10.1074/jbc.M212756200 ID - Mitoma2003 ER - TY - JOUR AU - Yeh, J. C. AU - Hiraoka, N. AU - Petryniak, B. AU - Nakayama, J. AU - Ellies, L. G. AU - Rabuka, D. PY - 2001 DA - 2001// TI - Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase JO - Cell VL - 105 UR - https://doi.org/10.1016/S0092-8674(01)00394-4 DO - 10.1016/S0092-8674(01)00394-4 ID - Yeh2001 ER - TY - JOUR AU - Cerhan, J. R. AU - Ansell, S. M. AU - Fredericksen, Z. S. AU - Kay, N. E. AU - Liebow, M. AU - Call, T. G. PY - 2007 DA - 2007// TI - Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-05-088682 DO - 10.1182/blood-2007-05-088682 ID - Cerhan2007 ER - TY - JOUR AU - He, M. AU - Wu, C. AU - Xu, J. AU - Guo, H. AU - Yang, H. AU - Zhang, X. PY - 2014 DA - 2014// TI - A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and alpha fetoprotein and their associations with cancer risk JO - Gut VL - 63 UR - https://doi.org/10.1136/gutjnl-2012-303434 DO - 10.1136/gutjnl-2012-303434 ID - He2014 ER - TY - JOUR AU - Ho, W. L. AU - Che, M. I. AU - Chou, C. H. AU - Chang, H. H. AU - Jeng, Y. M. AU - Hsu, W. M. PY - 2013 DA - 2013// TI - B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma JO - Cancer Sci VL - 104 UR - https://doi.org/10.1111/cas.12294 DO - 10.1111/cas.12294 ID - Ho2013 ER - TY - JOUR AU - Sato, T. AU - Gotoh, M. AU - Kiyohara, K. AU - Kameyama, A. AU - Kubota, T. AU - Kikuchi, N. PY - 2003 DA - 2003// TI - Molecular cloning and characterization of a novel human beta 1,4-N-acetylgalactosaminyltransferase, beta 4GalNAc-T3, responsible for the synthesis of N, N'-diacetyllactosediamine, galNAc beta 1–4GlcNAc JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M308857200 DO - 10.1074/jbc.M308857200 ID - Sato2003 ER - TY - JOUR AU - Fiete, D. AU - Mi, Y. AU - Oats, E. L. AU - Beranek, M. C. AU - Baenziger, J. U. PY - 2007 DA - 2007// TI - N-linked oligosaccharides on the low density lipoprotein receptor homolog SorLA/LR11 are modified with terminal GalNAc-4-SO4 in kidney and brain JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M606455200 DO - 10.1074/jbc.M606455200 ID - Fiete2007 ER - TY - JOUR AU - Hsu, W. M. AU - Che, M. I. AU - Liao, Y. F. AU - Chang, H. H. AU - Chen, C. H. AU - Huang, Y. M. PY - 2011 DA - 2011// TI - B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via beta(1) integrin signaling in neuroblastoma JO - Am J Pathol VL - 179 UR - https://doi.org/10.1016/j.ajpath.2011.05.025 DO - 10.1016/j.ajpath.2011.05.025 ID - Hsu2011 ER - TY - JOUR AU - Huang, J. AU - Liang, J. T. AU - Huang, H. C. AU - Shen, T. L. AU - Chen, H. Y. AU - Lin, N. Y. PY - 2007 DA - 2007// TI - Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells JO - Mol Cancer Res VL - 5 UR - https://doi.org/10.1158/1541-7786.MCR-06-0431 DO - 10.1158/1541-7786.MCR-06-0431 ID - Huang2007 ER - TY - JOUR AU - Che, M. I. AU - Huang, J. AU - Hung, J. S. AU - Lin, Y. C. AU - Huang, M. J. AU - Lai, H. S. PY - 2014 DA - 2014// TI - beta1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.1981 DO - 10.18632/oncotarget.1981 ID - Che2014 ER - TY - JOUR AU - Guo, S. AU - Sato, T. AU - Shirane, K. AU - Furukawa, K. PY - 2001 DA - 2001// TI - Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells JO - Glycobiology VL - 11 UR - https://doi.org/10.1093/glycob/11.10.813 DO - 10.1093/glycob/11.10.813 ID - Guo2001 ER - TY - JOUR AU - Almeida, R. AU - Amado, M. AU - David, L. AU - Levery, S. B. AU - Holmes, E. H. AU - Merkx, G. PY - 1997 DA - 1997// TI - A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3 JO - J Biol Chem VL - 272 UR - https://doi.org/10.1074/jbc.272.51.31979 DO - 10.1074/jbc.272.51.31979 ID - Almeida1997 ER - TY - JOUR AU - Chang, H. H. AU - Chen, C. H. AU - Chou, C. H. AU - Liao, Y. F. AU - Huang, M. J. AU - Chen, Y. H. PY - 2013 DA - 2013// TI - beta-1,4-Galactosyltransferase III enhances invasive phenotypes via beta1-integrin and predicts poor prognosis in neuroblastoma JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2367 DO - 10.1158/1078-0432.CCR-12-2367 ID - Chang2013 ER - TY - JOUR AU - Chen, C. H. AU - Wang, S. H. AU - Liu, C. H. AU - Wu, Y. L. AU - Wang, W. J. AU - Huang, J. PY - 2014 DA - 2014// TI - beta-1,4-Galactosyltransferase III suppresses beta1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer JO - Carcinogenesis VL - 35 UR - https://doi.org/10.1093/carcin/bgu007 DO - 10.1093/carcin/bgu007 ID - Chen2014 ER - TY - JOUR AU - Kingsley, P. D. AU - Hagen, K. G. AU - Maltby, K. M. AU - Zara, J. AU - Tabak, L. A. PY - 2000 DA - 2000// TI - Diverse spatial expression patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyl-transferase family member mRNAs during mouse development JO - Glycobiology VL - 10 UR - https://doi.org/10.1093/glycob/10.12.1317 DO - 10.1093/glycob/10.12.1317 ID - Kingsley2000 ER - TY - JOUR AU - Liu, J. AU - Yang, L. AU - Jin, M. AU - Xu, L. AU - Wu, S. PY - 2011 DA - 2011// TI - Regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2 JO - Mol Med Rep VL - 4 ID - Liu2011 ER - TY - JOUR AU - Ho, W. L. AU - Chou, C. H. AU - Jeng, Y. M. AU - Lu, M. Y. AU - Yang, Y. L. AU - Jou, S. T. PY - 2014 DA - 2014// TI - GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2627 DO - 10.18632/oncotarget.2627 ID - Ho2014 ER - TY - JOUR AU - Wu, Y. M. AU - Liu, C. H. AU - Hu, R. H. AU - Huang, M. J. AU - Lee, J. J. AU - Chen, C. H. PY - 2011 DA - 2011// TI - Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-1161 DO - 10.1158/0008-5472.CAN-11-1161 ID - Wu2011 ER - TY - JOUR AU - Lin, M. C. AU - Huang, M. J. AU - Liu, C. H. AU - Yang, T. L. AU - Huang, M. C. PY - 2014 DA - 2014// TI - GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity JO - Oral Oncol VL - 50 UR - https://doi.org/10.1016/j.oraloncology.2014.02.003 DO - 10.1016/j.oraloncology.2014.02.003 ID - Lin2014 ER - TY - JOUR AU - Steentoft, C. AU - Vakhrushev, S. Y. AU - Joshi, H. J. AU - Kong, Y. AU - Vester-Christensen, M. B. AU - Schjoldager, K. T. PY - 2013 DA - 2013// TI - Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology JO - EMBO J VL - 32 UR - https://doi.org/10.1038/emboj.2013.79 DO - 10.1038/emboj.2013.79 ID - Steentoft2013 ER - TY - JOUR AU - Soldati, R. AU - Berger, E. AU - Zenclussen, A. C. AU - Jorch, G. AU - Lode, H. N. AU - Salatino, M. PY - 2012 DA - 2012// TI - Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.26498 DO - 10.1002/ijc.26498 ID - Soldati2012 ER - TY - JOUR AU - Ito, K. AU - Stannard, K. AU - Gabutero, E. AU - Clark, A. M. AU - Neo, S. Y. AU - Onturk, S. PY - 2012 DA - 2012// TI - Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment JO - Cancer Metastasis Rev VL - 31 UR - https://doi.org/10.1007/s10555-012-9388-2 DO - 10.1007/s10555-012-9388-2 ID - Ito2012 ER - TY - JOUR AU - Shtivelman, E. AU - Bishop, J. M. PY - 1991 DA - 1991// TI - Expression of CD44 is repressed in neuroblastoma cells JO - Mol Cell Biol VL - 11 UR - https://doi.org/10.1128/MCB.11.11.5446 DO - 10.1128/MCB.11.11.5446 ID - Shtivelman1991 ER - TY - JOUR AU - Favrot, M. C. AU - Combaret, V. AU - Lasset, C. PY - 1993 DA - 1993// TI - CD44—a new prognostic marker for neuroblastoma JO - N Engl J Med VL - 329 UR - https://doi.org/10.1056/NEJM199312233292615 DO - 10.1056/NEJM199312233292615 ID - Favrot1993 ER - TY - JOUR AU - Fichter, M. AU - Hinrichs, R. AU - Eissner, G. AU - Scheffer, B. AU - Classen, S. AU - Ueffing, M. PY - 1997 DA - 1997// TI - Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C JO - Oncogene VL - 14 UR - https://doi.org/10.1038/sj.onc.1201127 DO - 10.1038/sj.onc.1201127 ID - Fichter1997 ER - TY - JOUR AU - Yu, A. L. AU - Gilman, A. L. AU - Ozkaynak, M. F. AU - London, W. B. AU - Kreissman, S. G. AU - Chen, H. X. PY - 2010 DA - 2010// TI - Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0911123 DO - 10.1056/NEJMoa0911123 ID - Yu2010 ER - TY - STD TI - Kushner BH, Ostrovnaya I, Cheung IY, Kuk D, Modak S, Kramer K, et al. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. Oncotarget. 2015. ID - ref100 ER - TY - JOUR AU - Rillahan, C. D. AU - Antonopoulos, A. AU - Lefort, C. T. AU - Sonon, R. AU - Azadi, P. AU - Ley, K. PY - 2012 DA - 2012// TI - Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome JO - Nat Chem Biol VL - 8 UR - https://doi.org/10.1038/nchembio.999 DO - 10.1038/nchembio.999 ID - Rillahan2012 ER - TY - JOUR AU - Marathe, D. D. AU - Buffone, A. AU - Chandrasekaran, E. V. AU - Xue, J. AU - Locke, R. D. AU - Nasirikenari, M. PY - 2010 DA - 2010// TI - Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-07-231480 DO - 10.1182/blood-2009-07-231480 ID - Marathe2010 ER - TY - JOUR AU - Miles, D. AU - Papazisis, K. PY - 2003 DA - 2003// TI - Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer JO - Clin Breast Cancer VL - 3 UR - https://doi.org/10.3816/CBC.2003.s.002 DO - 10.3816/CBC.2003.s.002 ID - Miles2003 ER - TY - JOUR AU - Westerlind, U. AU - Hobel, A. AU - Gaidzik, N. AU - Schmitt, E. AU - Kunz, H. PY - 2008 DA - 2008// TI - Synthetic vaccines consisting of tumor-associated MUC1 glycopeptide antigens and a T-cell epitope for the induction of a highly specific humoral immune response JO - Angew Chem Int Ed Engl VL - 47 UR - https://doi.org/10.1002/anie.200802102 DO - 10.1002/anie.200802102 ID - Westerlind2008 ER - TY - JOUR AU - Cai, H. AU - Huang, Z. H. AU - Shi, L. AU - Zhao, Y. F. AU - Kunz, H. AU - Li, Y. M. PY - 2011 DA - 2011// TI - Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using click chemistry JO - Chemistry VL - 17 UR - https://doi.org/10.1002/chem.201100217 DO - 10.1002/chem.201100217 ID - Cai2011 ER - TY - JOUR AU - Abdel-Aal, A. B. AU - Lakshminarayanan, V. AU - Thompson, P. AU - Supekar, N. AU - Bradley, J. M. AU - Wolfert, M. A. PY - 2014 DA - 2014// TI - Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist JO - Chembiochem VL - 15 UR - https://doi.org/10.1002/cbic.201402077 DO - 10.1002/cbic.201402077 ID - Abdel-Aal2014 ER - TY - JOUR AU - Kushner, B. H. AU - Cheung, I. Y. AU - Modak, S. AU - Kramer, K. AU - Ragupathi, G. AU - Cheung, N. K. PY - 2014 DA - 2014// TI - Phase I trial of a bivalent gangliosides vaccine in combination with beta-glucan for high-risk neuroblastoma in second or later remission JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1012 DO - 10.1158/1078-0432.CCR-13-1012 ID - Kushner2014 ER - TY - JOUR AU - Scursoni, A. M. AU - Galluzzo, L. AU - Camarero, S. AU - Lopez, J. AU - Lubieniecki, F. AU - Sampor, C. PY - 2011 DA - 2011// TI - Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer JO - Clin Dev Immunol VL - 2011 UR - https://doi.org/10.1155/2011/245181 DO - 10.1155/2011/245181 ID - Scursoni2011 ER - TY - JOUR AU - Cacciavillano, W. AU - Sampor, C. AU - Venier, C. AU - Gabri, M. R. AU - Davila, M. T. AU - Galluzzo, M. L. PY - 2015 DA - 2015// TI - A phase I study of the anti-idiotype vaccine racotumomab in neuroblastoma and other pediatric refractory malignancies JO - Pediatr Blood Cancer VL - 62 UR - https://doi.org/10.1002/pbc.25631 DO - 10.1002/pbc.25631 ID - Cacciavillano2015 ER - TY - JOUR AU - Serino, G. AU - Sallustio, F. AU - Cox, S. N. AU - Pesce, F. AU - Schena, F. P. PY - 2012 DA - 2012// TI - Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy JO - J Am Soc Nephrol VL - 23 UR - https://doi.org/10.1681/ASN.2011060567 DO - 10.1681/ASN.2011060567 ID - Serino2012 ER - TY - JOUR AU - Kahai, S. AU - Lee, S. C. AU - Lee, D. Y. AU - Yang, J. AU - Li, M. AU - Wang, C. H. PY - 2009 DA - 2009// TI - MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7 JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0007535 DO - 10.1371/journal.pone.0007535 ID - Kahai2009 ER - TY - JOUR AU - Gaziel-Sovran, A. AU - Segura, M. F. AU - Micco, R. AU - Collins, M. K. AU - Hanniford, D. AU - Vega-Saenz de Miera, E. PY - 2011 DA - 2011// TI - miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis JO - Cancer Cell VL - 20 UR - https://doi.org/10.1016/j.ccr.2011.05.027 DO - 10.1016/j.ccr.2011.05.027 ID - Gaziel-Sovran2011 ER - TY - JOUR AU - Wu, Q. AU - Liu, H. O. AU - Liu, Y. D. AU - Liu, W. S. AU - Pan, D. AU - Zhang, W. J. PY - 2015 DA - 2015// TI - Decreased expression of hepatocyte nuclear factor 4alpha (Hnf4alpha)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity JO - J Biol Chem VL - 290 UR - https://doi.org/10.1074/jbc.M114.601203 DO - 10.1074/jbc.M114.601203 ID - Wu2015 ER - TY - JOUR AU - Bernardi, C. AU - Soffientini, U. AU - Piacente, F. AU - Tonetti, M. G. PY - 2013 DA - 2013// TI - Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0076540 DO - 10.1371/journal.pone.0076540 ID - Bernardi2013 ER - TY - JOUR AU - Andolfo, I. AU - Liguori, L. AU - Antonellis, P. AU - Cusanelli, E. AU - Marinaro, F. AU - Pistollato, F. PY - 2012 DA - 2012// TI - The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma JO - Neuro Oncol VL - 14 UR - https://doi.org/10.1093/neuonc/nos002 DO - 10.1093/neuonc/nos002 ID - Andolfo2012 ER - TY - JOUR AU - Pan, S. AU - Cheng, X. AU - Chen, H. AU - Castro, P. D. AU - Ittmann, M. M. AU - Hutson, A. W. PY - 2013 DA - 2013// TI - ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC) JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0072829 DO - 10.1371/journal.pone.0072829 ID - Pan2013 ER - TY - JOUR AU - Sun, Y. AU - Yang, X. AU - Liu, M. AU - Tang, H. PY - 2016 DA - 2016// TI - B4GALT3 up-regulation by miR-27a contributes to the oncogenic activity in human cervical cancer cells JO - Cancer Lett VL - 375 UR - https://doi.org/10.1016/j.canlet.2016.03.016 DO - 10.1016/j.canlet.2016.03.016 ID - Sun2016 ER - TY - JOUR AU - Shusterman, S. AU - London, W. B. AU - Gillies, S. D. AU - Hank, J. A. AU - Voss, S. D. AU - Seeger, R. C. PY - 2010 DA - 2010// TI - Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children’s Oncology Group (COG) phase II study JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.8861 DO - 10.1200/JCO.2009.27.8861 ID - Shusterman2010 ER - TY - JOUR AU - Louis, C. U. AU - Savoldo, B. AU - Dotti, G. AU - Pule, M. AU - Yvon, E. AU - Myers, G. D. PY - 2011 DA - 2011// TI - Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-05-354449 DO - 10.1182/blood-2011-05-354449 ID - Louis2011 ER - TY - JOUR AU - Matsushita, T. PY - 2011 DA - 2011// TI - Engineered therapeutic antibodies with enhanced effector functions: clinical application of the potelligent(R) technology JO - Korean J Hematol VL - 46 UR - https://doi.org/10.5045/kjh.2011.46.3.148 DO - 10.5045/kjh.2011.46.3.148 ID - Matsushita2011 ER - TY - JOUR AU - Shinkawa, T. AU - Nakamura, K. AU - Yamane, N. AU - Shoji-Hosaka, E. AU - Kanda, Y. AU - Sakurada, M. PY - 2003 DA - 2003// TI - The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M210665200 DO - 10.1074/jbc.M210665200 ID - Shinkawa2003 ER - TY - JOUR AU - Topalian, S. L. AU - Hodi, F. S. AU - Brahmer, J. R. AU - Gettinger, S. N. AU - Smith, D. C. AU - McDermott, D. F. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - JOUR AU - Chen, R. AU - Peng, P. C. AU - Wen, B. AU - Li, F. Y. AU - Xie, S. AU - Chen, G. PY - 2016 DA - 2016// TI - Anti-programmed cell death (PD)-1 immunotherapy for malignant tumor: a systematic review and meta-analysis JO - Transl Oncol VL - 9 UR - https://doi.org/10.1016/j.tranon.2015.11.010 DO - 10.1016/j.tranon.2015.11.010 ID - Chen2016 ER - TY - JOUR AU - Mackall, C. L. AU - Merchant, M. S. AU - Fry, T. J. PY - 2014 DA - 2014// TI - Immune-based therapies for childhood cancer JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.177 DO - 10.1038/nrclinonc.2014.177 ID - Mackall2014 ER - TY - JOUR AU - Navid, F. AU - Sondel, P. M. AU - Barfield, R. AU - Shulkin, B. L. AU - Kaufman, R. A. AU - Allay, J. A. PY - 2014 DA - 2014// TI - Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.50.4423 DO - 10.1200/JCO.2013.50.4423 ID - Navid2014 ER - TY - JOUR AU - Cheung, N. K. AU - Guo, H. F. AU - Heller, G. AU - Cheung, I. Y. PY - 2000 DA - 2000// TI - Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma JO - Clin Cancer Res VL - 6 ID - Cheung2000 ER - TY - JOUR AU - Navid, F. AU - Santana, V. M. AU - Barfield, R. C. PY - 2010 DA - 2010// TI - Anti-GD2 antibody therapy for GD2-expressing tumors JO - Curr Cancer Drug Targets VL - 10 UR - https://doi.org/10.2174/156800910791054167 DO - 10.2174/156800910791054167 ID - Navid2010 ER -